Elaeocarpus grandis
Elaeocarpus grandis · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Elaeocarpus grandis is a fascinating botanical species that has become a subject of significant phytochemical interest. Scientific investigations into this plant frequently focus on the chemical composition of its leaves. Researchers have specifically identified unique secondary metabolites such as (-)-isoelaeocarpiline and Heterophylliin A within the foliage. These compounds are often isolated through specialized extraction processes using ethyl acetate and petroleum ether fractions. Understanding these chemical profiles provides valuable insights into the biological potential of this plant.
- Synonyms
- Elaeocarpus Drymophilus
- Common names
- Not available
- Family
- Elaeocarpaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Synonyms
Elaeocarpus grandis is a botanical species that is frequently identified within various scientific databases. In certain taxonomic records, this plant is also recognized by its synonym, Elaeocarpus drymophilus. This dual nomenclature can sometimes cause confusion for researchers navigating complex botanical literature. Understanding these linguistic connections is essential for maintaining accurate records of plant diversity. Therefore, recognizing both names ensures that studies regarding this species remain consistent and precise.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Elaeocarpus grandis is a distinctive member of the kingdom Plantae that belongs to the diverse family Elaeocarpaceae. Within this botanical hierarchy, the species is classified under the order Oxalidales. It further falls into the class Equisetopsida, showcasing its complex structural characteristics. Finally, this plant is identified by its specific placement within the genus Elaeocarpus.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Oxalidales |
| Family | Elaeocarpaceae |
| Genus | Elaeocarpus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Elaeocarpus grandis is a distinctive plant species with a broad geographical reach across several key regions. Its natural distribution extends through Australasia, specifically anchoring itself within the diverse landscapes of Australia. Within the Australian continent, it can be found thriving in both New South Wales and Queensland. The species also stretches into the Pacific, where it inhabits the Northwestern Pacific. Notably, this range includes the Caroline Islands, highlighting its ability to adapt to various island environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Elaeocarpus grandis develops into a robust tree that stands prominently within its ecosystem. As a self-supporting species, it maintains its own structural integrity without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Elaeocarpus grandis is a remarkable plant species that serves as a rich source of diverse bioactive secondary metabolites. Scientific investigations have confirmed that this species contains the compound heterophylliin A, which has demonstrated significant potential in managing type 2 diabetes. Specifically, molecular docking studies suggest that heterophylliin A can interact with key enzymes involved in glucose metabolism and reduce inflammatory markers. Additionally, the plant is known to contain isoelaeocarpiline, an indolizidine alkaloid found within its leaves. Beyond its metabolic implications, isoelaeocarpiline has also been identified as having a notable binding affinity for the human delta-opioid receptor.
Conditions
Elaeocarpus grandis exhibits significant pharmacological potential through its various bioactive alkaloids and metabolites. Certain compounds isolated from the plant, such as grandisines C, D, F, G, and (-)-isoelaeocarpiline, demonstrate receptor binding affinity for the human delta-opioid receptor. Additionally, the plant provides therapeutic benefits by treating streptozotocin-induced hyperglycemia in animal models. These hypoglycemic effects are particularly evident in the ethyl acetate and petroleum ether fractions of the species. Ultimately, these properties suggest that Elaeocarpus grandis can effectively treat type 2 diabetes mellitus (T2DM) by interacting with enzymes critical to glucose metabolism.
Preparations
Elaeocarpus grandis is prepared as ethyl acetate and petroleum ether fractions to investigate its medicinal properties. These specific fractions were utilized in a study to evaluate their hypoglycemic impact within a rat model of type 2 diabetes mellitus. Through chemical assessment of these prepared fractions, researchers successfully isolated and identified several known compounds. The metabolic profiling of these extracts further allowed for the provisional identification of sixteen distinct metabolites. Ultimately, these prepared fractions serve as the foundation for identifying bioactive constituents like heterophylliin A that interact with critical glucose metabolism enzymes.
Parts used
Elaeocarpus grandis serves as a significant source of diverse chemical compounds within the Australian rainforest. Researchers have successfully isolated several unique indolizidine alkaloids, known as grandisines C through G, directly from the leaves of this tree. Through the use of 1D and 2D NMR spectroscopy, the complex structural details of these leaf-derived molecules were precisely determined. These findings revealed novel ring systems and amino analogues that distinguish this plant's chemical profile. Furthermore, the alkaloids extracted from the foliage demonstrated notable binding affinity for the human delta-opioid receptor.